A bipartisan group of six senators introduced a bill to reform the 340B drug program, locking in hospitals’ use of contract pharmacies and adding new transparency and compliance rules. The legislation would also kill HHS’ contested rebate pilot within a year and replace it with a national data clearinghouse to catch duplicate discounts. The post…
According to a recent Health Affairs Perspective from Michael Chernew, the answer is ‘no’. In fact, physician and hospital prices may be too low. Although much has been made of high prices contributing to high spending in the US, 5 spending growth in Medicare is not driven by price growth. In fact, inflation-adjusted Medicare physician…
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. Imbalance of Power — And Healthcare Why can members of Congress remain on full taxpayer-funded salaries during prolonged medical absences while millions of working Americans cannot afford to get sick? (Kennedy,…
By MICHAEL MILLENSON “The New Yorker House Style Joins The Internet Age” announced the magazine’s daily newsletter under the byline of Andrew Boynton, whose appropriately old-fashioned title was “Head of Copy.” Among the alterations Boynton acknowledged readers might feel “long overdue,” were “Internet” becoming “internet,” “Web site” consolidating to “website” and “cell phone” becoming “cellphone.”…
CagriSema, a dual-acting drug in development by Novo Nordisk, met the goal of a Phase 3 test in patients with obesity and type 2 diabetes. But the topline results don’t show an advantage over Eli Lilly’s commercialized obesity medication, Zepbound. The post Novo Nordisk’s Next-Gen Obesity Drug Disappoints Again With Lower Than Expected Weight Loss…
When patients walked into Planned Parenthood clinics, a consumer data company sold their precise locations to anti-abortion groups for targeted ads. When patients picked up prescriptions for testosterone replacement therapy, law enforcement retrieved their names and addresses without a warrant. And when a father was arrested by immigration authorities, agents allegedly accessed his personal information…
The five-year federal reimbursement extension is changing how health systems think about Hospital at Home. Healthcare Innovation launches its new Digital Health Intelligence webinar series by exploring what comes next.
With better access to tools like CCTA and diagnostic tools that leverage CCTA, clinicians can better support their patients in managing overall cardiovascular health, patients will benefit from less invasive care and enhanced quality of life, and health systems could ultimately see reduced costs and streamlined workflows. The post How Expanded Reimbursement for Coronary CTA…
Healthcare startup exits are improving but remain highly selective. Jack Euston, general partner Fountain Health Partners, expects the next exit cycle to reward AI-enabled, workflow-embedded companies while sidelining undifferentiated point solutions and growth-at-all-costs models. The post What Will the Next Healthcare Exit Winners Look Like? appeared first on MedCity News.
CFO Celeste Mellet said the insurer is “not seeing anything” suggesting medical and pharmacy cost growth will slow in the coming year